Evaluation of the cyclin-dependent kinase inhibitor p21Cip1 in epithelial ovarian tumors of low malignant potential and adenocarcinomas.
暂无分享,去创建一个
P. Korkolopoulou | I. Thymara | I. Vassilopoulos | A. Konstantinidou | K. Pavlakis | E. Patsouris | C. Eftichiadis | M. Perdiki | E. Agapitos | P. Davaris